Literature DB >> 12533270

Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

Sanne B Schagen1, Martin J Muller, Willem Boogerd, Frits S A M Van Dam.   

Abstract

Currently, the interest in cognitive functioning following chemotherapy is rapidly expanding as is reflected in a growing number of published studies on this topic. Although most studies are indicative of cognitive deficits after chemotherapy, definite conclusions on the role of chemotherapy on cognitive function can often not be drawn due to methodological problems. On the basis of the studies on cognitive functioning after chemotherapy that are conducted in The Netherlands Cancer Institute, the current article describes a number of such methodological topics that obscure straightforward interpretation of neuropsychological findings in toxicity research. Measurement issues that diverge from usual assessment issues encountered in psychosocial oncology will be described, and factors that might play a role in the cause of cognitive impairment will be evaluated. Also, future developments necessary to gain more insight into the prevalence, the pattern, and the impact of cognitive problems following chemotherapy are discussed

Entities:  

Mesh:

Year:  2002        PMID: 12533270     DOI: 10.3816/cbc.2002.s.020

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  5 in total

1.  Instruments for estimation of health-related quality of life in patients with skull base neoplasms.

Authors:  Mariana E Witgert; Tracy Veramonti; Ehab Hanna
Journal:  Skull Base       Date:  2010-01

Review 2.  Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Authors:  Jeffrey S Wefel; Mariana E Witgert; Christina A Meyers
Journal:  Neuropsychol Rev       Date:  2008-04-16       Impact factor: 7.444

3.  Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.

Authors:  John J Foley; Robert B Raffa; Ellen A Walker
Journal:  Psychopharmacology (Berl)       Date:  2008-05-08       Impact factor: 4.530

Review 4.  A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.

Authors:  Miyuki Ono; James M Ogilvie; Jennifer S Wilson; Heather J Green; Suzanne K Chambers; Tamara Ownsworth; David H K Shum
Journal:  Front Oncol       Date:  2015-03-10       Impact factor: 6.244

5.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

Authors:  V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.